Revolution Medicines (RVMD) Other Non-Current Assets (2019 - 2026)
Revolution Medicines (RVMD) posted Other Non-Current Assets of $42.5 million for Q2 2026, up 22.31% on a QoQ basis from $34.7 million in Q1 2026, and up 35.12% year-over-year from $31.4 million in Q2 2025.
Powered by 
Analysis
Revolution Medicines (RVMD) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Revolution Medicines has reported Other Non-Current Assets for 8 years, with the latest figure at $42.5 million in Q2 2026.
- On a quarterly basis, Other Non-Current Assets rose 35.12% year-over-year to $42.5 million in Q2 2026; TTM through Jun 2026 was $42.5 million, a 35.12% increase from a year earlier, with the FY2025 full-year figure at $24.1 million, up 99.11% from the prior year.
- Other Non-Current Assets was $42.5 million for Q2 2026 at Revolution Medicines, up from $34.7 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $42.5 million in Q2 2026, with the low at $1.7 million in Q1 2022.
- Average Other Non-Current Assets over 5 years is $12.7 million, with a median of $9.3 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets surged 553.54% in 2023, then slipped 9.49% in 2024.
- Over 5 years, Other Non-Current Assets stood at $2.9 million in 2022, then surged by 146.13% to $7.0 million in 2023, then soared by 72.47% to $12.1 million in 2024, then surged by 99.11% to $24.1 million in 2025, then soared by 75.81% to $42.5 million in 2026.
- The last three Other Non-Current Assets figures came in at $42.5 million (Q2 2026), $34.7 million (Q1 2026), and $24.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | - |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Revolution Medicines | 40.86 Bn | 40.86 Bn | - | 42.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.45 Mn |
| Mar 31, 2026 | 34.71 Mn |
| Dec 31, 2025 | 24.15 Mn |
| Sep 30, 2025 | 16.85 Mn |
| Jun 30, 2025 | 31.42 Mn |
| Mar 31, 2025 | 13.13 Mn |
| Dec 31, 2024 | 12.13 Mn |
| Sep 30, 2024 | 10.28 Mn |
| Jun 30, 2024 | 8.27 Mn |
| Mar 31, 2024 | 4.16 Mn |
| Dec 31, 2023 | 7.03 Mn |
| Sep 30, 2023 | 11.35 Mn |
| Jun 30, 2023 | 2.69 Mn |
| Mar 31, 2023 | 2.77 Mn |
| Dec 31, 2022 | 2.86 Mn |
| Sep 30, 2022 | 1.74 Mn |
| Jun 30, 2022 | 1.74 Mn |
| Mar 31, 2022 | 1.74 Mn |
| Dec 31, 2021 | 1.74 Mn |
| Sep 30, 2021 | 1.08 Mn |
API Access
Revolution Medicines Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();